The Pentagon retreated and temporarily suspended a clinical guidance that had been published only a day earlier. The guidance provided for new mandatory screening for testosterone deficiency for military personnel aged 30 or older.
The decision to suspend the new hormone screening rules was made quickly after the initial publication of the clinical guidance. The Pentagon did not specify the reasons for the retreat nor when the rules could be re-implemented.
The measure would affect all US military personnel who were 30 years of age or older, making testosterone screening mandatory. This temporary suspension occurs at a time when military health policies have received increasing attention.
